---
schema_version: "secwatch.filing_event.v1"
accession: "0000898432-24-000224"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2024-03-13T23:59:59+00:00"
generated_at: "2026-06-04T22:30:41.116165+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Bellevue Life Sciences Acquisition Corp. issues $60K promissory note to Josh Pan for business combination extension

## Summary
- On March 8, 2024, Bellevue Life Sciences issued a $60,000 unsecured promissory note to Josh Pan, member of sponsor Bellevue Capital Management, LLC.
- Note is non-interest bearing, due August 8, 2024 or upon consummation of an initial business combination, with principal forgiven if no deal occurs.
- On March 12, 2024, $60,000 deposited into trust account to extend business combination deadline from March 14, 2024 to April 15, 2024.
- Event of default includes payment failure within five business days of maturity or bankruptcy proceedings.

## SEC filing metadata
- accession: 0000898432-24-000224
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2024-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000089843224000224/0000898432-24-000224-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000089843224000224/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000898432-24-000224
- JSON: https://secwatch.observer/filing/0000898432-24-000224.json
- Plain text: https://secwatch.observer/filing/0000898432-24-000224.txt

## Key facts
- Debt Financings
  OSR Holdings, Inc. incurred loan of $60,000 with Josh Pan at not interest bearing maturing earlier of: (i) August 8, 2024 or (ii) the date on which the Company consummates an initial business combination.
  - Instrument: loan
  - Principal: $60,000
  - Counterparty: Josh Pan
  - Rate: not interest bearing
  - Maturity: earlier of: (i) August 8, 2024 or (ii) the date on which the Company consummates an initial business combination
  - Event: incurrence
  source text: On March 8, 2024, Bellevue Life Sciences Acquisition Corp. (the “ Company ”) issued an unsecured promissory note (the “ Promissory Note ”) in the principal amount of $60,000 to Josh Pan
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840425/000089843224000224/0000898432-24-000224-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.